Voxzogo (Vosoritide)

Voxzogo (Vosoritide)

Voxzogo

Vosoritide

Injection: 0.4 mg, 0.56 mg, or 1.2 mg lyophilized powder in a single-dose

BioMarin Pharmaceutical Inc.

Medical Use

Voxzogo is a C-type natriuretic peptide (CNP) analog designed to promote linear growth in children aged 5 years and older with achondroplasia, provided they have open growth plates (epiphyses).

Recommended Dosage: The dosage of Voxzogo is determined by the child’s actual body weight. Typically, the dose is 15 µg/kg of body weight, administered via subcutaneous injection once daily. It’s best to administer the injection at the same time each day. The volume of the injection depends on the child’s weight and the concentration of the reconstituted Voxzogo solution (either 0.8 mg/mL or 2 mg/mL). The medication must be reconstituted before use.

Missed Dose: If a dose is missed, it can be given within 12 hours of the scheduled time. If more than 12 hours have passed, skip the missed dose and continue with the next scheduled dose.